INGREZZA
Live / Registered — Registered (as of 06 Aug 2024)
What this means for you
Registered since 06 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97978257
- Registration number
- 7469796
- Mark type
- Design + words
- Filed
- 11 Nov 2022
- Published for opposition
- 10 Oct 2023
- Registered
- 06 Aug 2024
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for movement disorders, namely, chorea associated with Huntington's Disease
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Jun 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 11 Jun 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Jun 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 May 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Apr 2024 — USE AMENDMENT FILED